Maintenance treatment with buprenorphine and naltrexone for heroin dependence in Malaysia: a randomised, double-blind, placebo-controlled trial
about
Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependenceOral substitution treatment of injecting opioid users for prevention of HIV infectionOral naltrexone maintenance treatment for opioid dependenceOral naltrexone maintenance treatment for opioid dependenceOpioid substitution and antagonist therapy trials exclude the common addiction patient: a systematic review and analysis of eligibility criteriaThe globalization of addiction research: capacity-building mechanisms and selected examplesHealth and human rights concerns of drug users in detention in Guangxi Province, ChinaCost-effectiveness of buprenorphine and naltrexone treatments for heroin dependence in MalaysiaAlcohol and Opioid Use Disorder in Older Adults: Neglected and Treatable Illnesses.Behavioral drug and HIV risk reduction counseling (BDRC) in MMT programs in Wuhan, China: a pilot randomized clinical trial.HIV risk behavior in treatment-seeking opioid-dependent youth: results from a NIDA clinical trials network multisite study.Dronabinol for the treatment of cannabis dependence: a randomized, double-blind, placebo-controlled trialDrug treatment as HIV prevention: a research updateDrug treatment as HIV prevention: expanding treatment options.Maintenance medication for opiate addiction: the foundation of recovery.Costs of addressing heroin addiction in Malaysia and 32 comparable countries worldwide.Adherence to Buprenorphine Maintenance Treatment in Opioid Dependence Syndrome: A Case Control Study.The newer Opioid Agonist Treatment with lower substitutive opiate doses is associated with better toxicology outcome than the older Harm Reduction Treatment.Retention of participants in medication-assisted programs in low- and middle-income countries: an international systematic review.Pharmacotherapies for treating opioid use disorder.The Availability of Ancillary Counseling in the Practices of Physicians Prescribing Buprenorphine.The relative risk of HIV among IDUs not in treatment in Malaysia.Compliance with buprenorphine medication-assisted treatment and relapse to opioid use.Medical treatments for opioid use disorder in Iran: a randomized, double-blind placebo-controlled comparison of buprenorphine/naloxone and naltrexone maintenance treatment.Double trouble-pregnancy and antagonist treatment in opioid dependence; two contentious issues needing further consideration and research.Advances in the delivery of buprenorphine for opioid dependence.Emerging Drug Use Trends in Kelantan, Malaysia.Atomoxetine for amphetamine-type stimulant dependence during buprenorphine treatment: A randomized controlled trial.Suboxone: Rationale, Science, Misconceptions.
P2860
Q24200539-0723B7FE-694C-49FD-A0C0-F33801ACDD54Q24234956-7DD20867-8347-4CEC-B72E-7D59E0AB097AQ24235092-78B53279-5C62-4FD3-8916-8B8689D4070CQ24236708-3A28F526-C24C-44AC-9EEF-ACA4053C2FE5Q26778626-51D0D7D7-00DB-4EEA-914A-B8F91A661E86Q27016126-76D31A45-C55F-4EF5-8BC1-382BC4F75044Q28474306-A65FAFDB-691D-4CBA-BED6-0C901665E055Q28485456-13D40DBD-E463-4FEA-9F00-C21125972AA3Q30248638-E6AEAF25-D98A-4125-A17C-D95854AD18FEQ34792063-C3750E04-5BE2-4167-B824-6FB5CE39F3BFQ35143605-245391A1-51EB-4F01-92DC-2F98590409A7Q35160234-26B96B86-0822-44F9-A523-E2DD25D3FD59Q35163392-3332B0F3-2DFF-4006-B242-6DA1A2CB1864Q35163396-2CED9C44-A4ED-454D-9266-90AFBBA5E81CQ36138164-DC45B5F4-58A7-4EF5-9D48-BEF73E7D8637Q36166640-274FAE8A-3D75-4B64-88B1-D1FCE3E9A560Q36291882-D6A443B2-B04E-4E7D-AB67-846C899E8ED5Q37442770-7B0982EC-E8A1-47FA-BD8A-103E01EA1DF9Q37645900-3D4E2486-4D68-4AAD-9104-83F805E95263Q38096571-A25FC16F-8D2F-45E4-89FA-035CCD2E9D33Q40396333-93C61BB1-A99F-40DA-BD13-8ECED7DE9833Q42643534-3DF2D922-3A71-4967-BE23-2D183A230C31Q44332334-B55C8590-6A8A-4408-9285-2CEB253FD461Q44333905-871FC0D0-BC09-4F01-8EC1-5A139F2C9DC2Q44337590-3DCB4849-0A3E-4F64-8341-B4831584AE22Q45946172-40DFB836-20C5-40A4-849F-3F6B05626120Q50207930-57E43DB6-1B0D-496C-A41D-43252D493E9CQ51735563-72F3402C-89C4-4785-B062-16508F4B7211Q52645984-5E698522-66B0-40D0-A630-B9A0AEA90366
P2860
Maintenance treatment with buprenorphine and naltrexone for heroin dependence in Malaysia: a randomised, double-blind, placebo-controlled trial
description
2008 nî lūn-bûn
@nan
2008 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Maintenance treatment with bup ...... lind, placebo-controlled trial
@ast
Maintenance treatment with bup ...... lind, placebo-controlled trial
@en
type
label
Maintenance treatment with bup ...... lind, placebo-controlled trial
@ast
Maintenance treatment with bup ...... lind, placebo-controlled trial
@en
prefLabel
Maintenance treatment with bup ...... lind, placebo-controlled trial
@ast
Maintenance treatment with bup ...... lind, placebo-controlled trial
@en
P2093
P2860
P921
P1433
P1476
Maintenance treatment with bup ...... lind, placebo-controlled trial
@en
P2093
Mahmud Mazlan
Marek C Chawarski
Richard S Schottenfeld
P2860
P304
P356
10.1016/S0140-6736(08)60954-X
P407
P577
2008-06-01T00:00:00Z